Identifying aberrant pathways through integrated analysis of knowledge in pharmacogenomics
about
The Semanticscience Integrated Ontology (SIO) for biomedical research and knowledge discoveryMining Electronic Health Records using Linked DataKaBOB: ontology-based semantic integration of biomedical databases.The functional therapeutic chemical classification systemThe ChEBI reference database and ontology for biologically relevant chemistry: enhancements for 2013A rule-based ontological framework for the classification of molecules.The Disease Ontology: fostering interoperability between biological and clinical human disease-related data.Learning from biomedical linked data to suggest valid pharmacogenes.Semantic prioritization of novel causative genomic variantsEnrichment analysis applied to disease prognosisDrug target inference through pathway analysis of genomics data.HPOSim: an R package for phenotypic similarity measure and enrichment analysis based on the human phenotype ontology.The anatomy of phenotype ontologies: principles, properties and applications.Analysis of the human diseasome using phenotype similarity between common, genetic, and infectious diseasesDrug-pathway interaction prediction via multiple feature fusion.Integrating phenotype ontologies with PhenomeNET.Inferring ontology graph structures using OWL reasoning.Ontologies in ChemoinformaticsOntologies in CheminformaticsChemical Ontologies for Standardization, Knowledge Discovery, and Data Mining
P2860
Q19671659-347D95A5-9EBB-415E-AD02-54DA7D9D1F54Q28645606-936F7C6C-F55E-4063-BF5E-A50886F3CB40Q28646864-7D53A944-A703-4BAB-BFC3-552195C2EA39Q28657672-B467B2AA-D955-4EEF-8C93-03850F5BF794Q28710191-F894A0FC-5D49-4197-94FA-217CDF776879Q30486892-413FD09E-CC53-495D-B4E2-02E20A80ECCDQ30975553-8585A752-8FFD-415C-BFBD-2947EEAC4D5FQ33587530-B7AADF1C-1239-4D0A-BC95-DF3E89B7948FQ33620978-A38083C7-8B2B-4E8E-8DA0-782969A5B8D6Q34018532-755802F6-77F4-459E-ABE8-7FA0550620EAQ34570294-9DE7BA7C-B010-421F-9D1F-0989E8483B6AQ35064295-320CFA9E-23EF-4063-98D5-73C01DDB14D5Q38378393-DCD01CEF-9650-4C74-8CBF-2C948ED45D3BQ38410296-6376B5FC-ECF0-470A-A606-226F8BF21030Q38425392-D50A1717-09E3-4CFA-B77D-5935C0ECBCBDQ47107332-DC556331-7910-4C29-836C-D237233A3903Q47198116-765EE443-1563-4BFB-9BE4-33599961B10AQ56603996-D6F779C7-B835-41C8-A1B3-5CC6DE0C7D85Q56603998-E6F230C0-6265-4BDF-91F8-EF77DA40DDB7Q56604008-B51BAA7E-F61B-4FFF-8572-374D05277FF9
P2860
Identifying aberrant pathways through integrated analysis of knowledge in pharmacogenomics
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Identifying aberrant pathways ...... knowledge in pharmacogenomics
@ast
Identifying aberrant pathways ...... knowledge in pharmacogenomics
@en
type
label
Identifying aberrant pathways ...... knowledge in pharmacogenomics
@ast
Identifying aberrant pathways ...... knowledge in pharmacogenomics
@en
prefLabel
Identifying aberrant pathways ...... knowledge in pharmacogenomics
@ast
Identifying aberrant pathways ...... knowledge in pharmacogenomics
@en
P2860
P50
P356
P1433
P1476
Identifying aberrant pathways ...... knowledge in pharmacogenomics
@en
P2860
P304
P356
10.1093/BIOINFORMATICS/BTS350
P407
P577
2012-06-17T00:00:00Z